Genetic expression patterns of the neurotrophin receptors in DMG tumours (Extended Data Fig. 1a), suggests that BDNF acts on glioma cells through the TrkB (encoded by NTRK2) receptor and that BDNF is a key neurotrophin to which paediatric glioma cells respond. Here, NTRK2 is linked to central nervous system cancer.